Emerging in the field of obesity treatment, retatrutide presents a distinct strategy. Unlike many current medications, retatrutide works as a twin agonist, simultaneously affecting both GLP-like peptide-1 (GLP-1) and https://sachinjdzl525544.blogofoto.com/69840466/a-innovative-retatrutide-a-glp-gip-receptor-agonist